Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist

British Journal of Pharmacology

Volumn , Issue , 2016, Pages 2614-2621

  Bischof, Jocelyn M ^a   Van Der Ploeg, Lex H T ^b   Colmers, William F ^a   Wevrick, Rachel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Rhythm Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROOPIOMELANOCORTIN; SETMELANOTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; ENERGY EXPENDITURE; FOOD INTAKE; HORMONE SUBSTITUTION; LIGHT DARK CYCLE; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

EID: 84981274731     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13540     Document Type: Article

References (25)

1. Alexander SP, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015). The concise guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
2. Bischof JM, Stewart CL, Wevrick R (2007). Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader–Willi syndrome. Hum Mol Genet 16: 2713–2719.
3. Chen KY, Muniyappa R, Abel BS, Mullins KP, Staker P, Brychta RJ et al. (2015). RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. J Clin Endocrinol Metab 100: 1639–1645.
4. Clemmensen C, Finan B, Fischer K, Tom RZ, Legutko B, Sehrer L et al. (2015). Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice. EMBO Mol Med 7: 288–298.
5. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA et al. (2015). Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 172: 3461–3471.
6. Gottesdiener K, Conners H, Van der Ploeg L, Fiedorek F, Hylan M, Louis W et al. (2015). T-P-3134: analysis of the synthetic peptide setmelanotide (RM-493), a melanocortin-4 receptor (MC4R) agonist, on cardiovascular parameters in three phase1b/2a studies. Oral abstract presentation at: The Obesity Society Annual Meeting at ObesityWeekSM 2014; November 2-7, 2014; Boston, MA. www.obesityweek.com.
7. Hansen MJ, Ball MJ, Morris MJ (2001). Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892: 130–137.
8. Jequier E, Acheson K, Schutz Y (1987). Assessment of energy expenditure and fuel utilization in man. Annu Rev Nutr 7: 187–208.
9. Kievit P, Halem H, Marks DL, Dong JZ, Glavas MM, Sinnayah P et al. (2013). Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes 62: 490–497.
10. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010). Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharm Pharmacol 1: 94–99.
11. Kozlov SV, Bogenpohl JW, Howell MP, Wevrick R, Panda S, Hogenesch JB et al. (2007). The imprinted gene Magel2 regulates normal circadian output. Nat Genet 39: 1266–1272.
12. Kumar KG, Sutton GM, Dong JZ, Roubert P, Plas P, Halem HA et al. (2009). Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides 30: 1892–1900.
13. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J et al. (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39–51.
14. Lee S, Kozlov S, Hernandez L, Chamberlain SJ, Brannan CI, Stewart CL et al. (2000). Expression and imprinting of MAGEL2 suggest a role in Prader–Willi syndrome and the homologous murine imprinting phenotype. Hum Mol Genet 9: 1813–1819.
15. Li G, Zhang Y, Wilsey JT, Scarpace PJ (2004). Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression. J Endocrinol 182: 123–132.
16. McGrath JC, Lilley E (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189–3193.
17. Mercer RE, Kwolek EM, Bischof JM, van Eede M, Henkelman RM, Wevrick R (2009). Regionally reduced brain volume, altered serotonin neurochemistry, and abnormal behavior in mice null for the circadian rhythm output gene Magel2. Am J Med Genet B Part B, Neuropsychiatr Genet 150B: 1085–1099.
18. Mercer RE, Michaelson SD, Chee MJ, Atallah TA, Wevrick R, Colmers WF (2013). Magel2 is required for leptin-mediated depolarization of POMC neurons in the hypothalamic arcuate nucleus in mice. PLoS Genet 9: e1003207.
19. Pravdivyi I, Ballanyi K, Colmers WF, Wevrick R (2015). Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader–Willi syndrome. Hum Mol Genet 24: 4276–4283.
20. Resnick JL, Nicholls RD, Wevrick R, Prader-Willi Syndrome Animal Models Working G (2013). Recommendations for the investigation of animal models of Prader–Willi syndrome. Mamm Genome 24: 165–178.
21. Scarpace PJ, Matheny M, Zolotukhin S, Tumer N, Zhang Y (2003). Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II. Neuropharmacology 45: 211–219.
22. Schaaf CP, Gonzalez-Garay ML, Xia F, Potocki L, Gripp KW, Zhang B et al. (2013). Truncating mutations of MAGEL2 cause Prader–Willi phenotypes and autism. Nat Genet 45: 1405–1408.
23. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res 44: D1054–D1068.
24. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999). Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5: 1066–1070.
25. Yeo GS, Heisler LK (2012). Unraveling the brain regulation of appetite: lessons from genetics. Nat Neurosci 15: 1343–1349.